Henrickson Nauta Wealth Advisors, Inc. Gilead Sciences, Inc. Transaction History
Henrickson Nauta Wealth Advisors, Inc.
- $282 Million
- Q2 2025
A detailed history of Henrickson Nauta Wealth Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Henrickson Nauta Wealth Advisors, Inc. holds 7,066 shares of GILD stock, worth $821,069. This represents 0.28% of its overall portfolio holdings.
Number of Shares
7,066
Previous 7,052
0.2%
Holding current value
$821,069
Previous $790,000
0.89%
% of portfolio
0.28%
Previous 0.31%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
2,294Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$14 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.92 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.35 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.22 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $146B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...